- Home
- DNTH vs DCOM Comparison
DNTH vs DCOM Comparison
Compare DNTH & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNTH | DCOM |
|---|---|---|
| Founded | 2015 | 1864 |
| Country | United States | United States |
| Employees | N/A | 902 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | DNTH | DCOM |
|---|---|---|
| Price | $95.00 | $36.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $121.00 | $36.40 |
| AVG Volume (30 Days) | ★ 844.8K | 252.9K |
| Earning Date | 05-11-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 2.77% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,036,000.00 | N/A |
| Revenue This Year | N/A | $21.40 |
| Revenue Next Year | $29.48 | $12.65 |
| P/E Ratio | ★ N/A | $14.81 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.77 | $24.41 |
| 52 Week High | $92.27 | $36.86 |
Technical Indicators
Market Signals| Indicator | DNTH | DCOM |
|---|---|---|
| Relative Strength Index (RSI) | 76.73 | 72.16 |
| Support Level | $33.94 | $25.69 |
| Resistance Level | N/A | $36.86 |
| Average True Range (ATR) | 4.54 | 0.84 |
| MACD | 0.13 | 0.31 |
| Stochastic Oscillator | 97.35 | 92.83 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. The company gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, and mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.